Cancer Management Branch, Research Institute, National Cancer Center, 809, Madu-dong, Ilsan-gu, Goyang-si, Gyeonggi-do, 411-769, Korea.
J Clin Oncol. 2011 Jun 20;29(18):2474-80. doi: 10.1200/JCO.2010.30.1184. Epub 2011 May 16.
We conducted this study to evaluate the validity of the perception that awareness of their terminal prognosis and use of palliative care or nonuse of an intensive care unit (ICU) causes patients to die sooner than they would otherwise.
In this prospective cohort study at 11 university hospitals and the National Cancer Center in Korea, we administered questionnaires to 619 consecutive patients immediately after they were determined by physicians to be terminally ill. We followed patients during 6 months after enrollment and assessed how their survival was affected by the disclosure of terminal illness and administration of palliative care or nonuse of the ICU.
In a follow-up of 481 patients and 163.8 person-years, we identified 466 deceased patients. Nineteen percent of the patients died within 1 month, while 41.3% lived for 3 months, and 17.7% lived for 6 months. Once the cancer was judged terminal, the median survival time was 69 days. On multivariate analysis, neither patient awareness of terminal status at baseline (adjusted hazard ratio [aHR], 1.20; 95% CI, 0.96 to 1.51), use of a palliative care facility (aHR, 0.96; 95% CI, 0.76 to 1.21), nor general prostration (aHR, 1.23; 95% CI, 0.96 to 1.57) was associated with reduced survival. Use of the ICU (aHR, 1.47; 95% CI, 1.06 to 2.05) and poor Eastern Cooperative Oncology Group performance status (aHR, 1.37; 95% CI, 1.10 to 1.71) were significantly associated with poor survival.
Patients' being aware that they are dying and entering a palliative care facility or ICU does not seem to influence patients' survival.
我们开展这项研究旨在评估这样一种观点的有效性,即患者对其终末预后的认知以及使用姑息治疗或不使用重症监护病房(ICU)会导致他们比预期更早地死亡。
在韩国的 11 所大学医院和国家癌症中心进行的这项前瞻性队列研究中,我们在医生确定患者处于终末期后立即向 619 名连续患者发放问卷。我们在入组后 6 个月内对患者进行随访,并评估终末期疾病的披露以及姑息治疗的实施或 ICU 的不使用对患者生存的影响。
在对 481 名患者和 163.8 人年的随访中,我们确定了 466 名死亡患者。19%的患者在 1 个月内死亡,而 41.3%的患者存活 3 个月,17.7%的患者存活 6 个月。一旦癌症被判断为终末期,中位生存时间为 69 天。多变量分析显示,患者在基线时对终末期状态的认知(调整后的危险比[HR],1.20;95%置信区间[CI],0.96 至 1.51)、姑息治疗设施的使用(HR,0.96;95%CI,0.76 至 1.21)或一般衰竭(HR,1.23;95%CI,0.96 至 1.57)均与生存时间缩短无关。使用 ICU(HR,1.47;95%CI,1.06 至 2.05)和较差的东部合作肿瘤学组表现状态(HR,1.37;95%CI,1.10 至 1.71)与较差的生存显著相关。
患者意识到自己即将死亡并进入姑息治疗机构或 ICU 似乎不会影响患者的生存。